Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jüni

Showing results (1-10 of 534) with videos related to

Pageof 54
Sort By:
Zeitschrift Fur Orthopadie Und Unfallchirurgie|December 17, 2010
[Interview - cartilage components do not help against arthritis]Peter Jüni
The New England Journal of Medicine|July 21, 2021
PCI for Nonculprit Lesions in Patients with STEMI - No Role for FFRPeter Jüni
European Heart Journal|March 3, 2011
An overview of the objectives of and the approaches to propensity score analysesGeorg Heinze, Peter Jüni
Circulation|February 11, 2009
The drug-eluting stent sagaStephan Windecker, Peter Jüni
Lancet (London, England)|October 13, 2009
PRISMAtic reporting of systematic reviews and meta-analysesPeter Jüni, Matthias Egger
Nature Clinical Practice. Cardiovascular Medicine|April 17, 2008
Safety of drug-eluting stentsStephan Windecker, Peter Jüni
The New England Journal of Medicine|July 5, 2013
Patent foramen ovale and cryptogenic strokeBernhard Meier, Peter Jüni
International Journal of Epidemiology|January 15, 2005
Commentary: Empirical evidence of attrition bias in clinical trialsPeter Jüni, Matthias Egger
International Journal of Epidemiology|December 17, 2008
Commentary: Which meta-analyses are conclusive?Eveline Nüesch, Peter Jüni
JAMA|November 19, 2002
Allocation concealment in clinical trialsPeter Jüni, Matthias Egger
Pageof 54

Showing results (1-10 of 534) with videos related to

Sort By:
Pageof 54
Zeitschrift Fur Orthopadie Und Unfallchirurgie|December 17, 2010
[Interview - cartilage components do not help against arthritis]Peter Jüni
The New England Journal of Medicine|July 21, 2021
PCI for Nonculprit Lesions in Patients with STEMI - No Role for FFRPeter Jüni
European Heart Journal|March 3, 2011
An overview of the objectives of and the approaches to propensity score analysesGeorg Heinze, Peter Jüni
Circulation|February 11, 2009
The drug-eluting stent sagaStephan Windecker, Peter Jüni
Lancet (London, England)|October 13, 2009
PRISMAtic reporting of systematic reviews and meta-analysesPeter Jüni, Matthias Egger
Nature Clinical Practice. Cardiovascular Medicine|April 17, 2008
Safety of drug-eluting stentsStephan Windecker, Peter Jüni
The New England Journal of Medicine|July 5, 2013
Patent foramen ovale and cryptogenic strokeBernhard Meier, Peter Jüni
International Journal of Epidemiology|January 15, 2005
Commentary: Empirical evidence of attrition bias in clinical trialsPeter Jüni, Matthias Egger
International Journal of Epidemiology|December 17, 2008
Commentary: Which meta-analyses are conclusive?Eveline Nüesch, Peter Jüni
JAMA|November 19, 2002
Allocation concealment in clinical trialsPeter Jüni, Matthias Egger
Pageof 54